PacWest Bancorp

PACWEST ALERT: Bragar Eagel & Squire, P.C. is Investigating PacWest Bancorp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
星期三, 五月 15, 2024
PacWest, PacWest Bancorp, PWB, Telephone, Complaint, Defendant, P.C

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against PacWest Bancorp (NASDAQ: PACW) on behalf of long-term stockholders following a class action complaint that was filed against PacWest on September 11, 2023 with a Class Period from February 28, 2022 and May 3, 2023.

Key Points: 
  • NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against PacWest Bancorp (NASDAQ: PACW) on behalf of long-term stockholders following a class action complaint that was filed against PacWest on September 11, 2023 with a Class Period from February 28, 2022 and May 3, 2023.
  • Our investigation concerns whether the board of directors of PacWest have breached their fiduciary duties to the company.
  • According to the complaint, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
  • There is no cost or obligation to you.

Banc of California Hires Ann DeVries as Head of Investor Relations

Retrieved on: 
星期三, 五月 8, 2024
Banking, Professional Services, Finance, Kauder, Small business, JPMorgan Chase, Jack de Vries (soccer), Business development, Communication, Columbia University, Research, Banc of California, PacWest Bancorp, Senior, Institute of Management Accountants, BANC, Smith College, Banq, Knowledge, Head, Management

Banc of California, a wholly owned subsidiary of Banc of California, Inc. (NYSE: BANC), announced today that Ann DeVries has joined as Senior Vice President, Strategic Finance and Head of Investor Relations.

Key Points: 
  • Banc of California, a wholly owned subsidiary of Banc of California, Inc. (NYSE: BANC), announced today that Ann DeVries has joined as Senior Vice President, Strategic Finance and Head of Investor Relations.
  • In this newly created position, she is responsible for Banc of California’s investor relations strategy, investor and research analyst outreach, and communication with current and potential investors.
  • DeVries is based in New York City and reports to Joe Kauder, Executive Vice President and Chief Financial Officer.
  • Previously, DeVries spent 16 years at JPMorgan Chase & Co., where she held a series of increasingly senior roles in investment banking, financial reporting and investor relations.

Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Retrieved on: 
星期五, 五月 3, 2024
Cancer, Irritable bowel syndrome, Phenotype, IL-2, Food, Research, Pembrolizumab, Colitis, Immunotherapy, PacWest Bancorp, Tumor microenvironment, Defecation, ASCO, Therapy, Immunology, Patient, Society, BPR, Poster, Clinical trial, Annual general meeting, Non-Hodgkin lymphoma, Food and Drug Administration, DSM-IV codes, Pharmaceutical industry

“Werewolf continues to focus on the execution of our lead clinical programs WTX-124 and WTX-330, with updates planned for later in the second quarter.

Key Points: 
  • “Werewolf continues to focus on the execution of our lead clinical programs WTX-124 and WTX-330, with updates planned for later in the second quarter.
  • Financial Results for the First Quarter of 2024:
    Cash position: As of March 31, 2024, cash and cash equivalents were $139.2 million, compared to $134.3 million as of December 31, 2023.
  • General and administrative expenses: General and administrative expenses were $5.0 million for each of the first quarters of 2024 and 2023.
  • Net loss: Net loss was $16.2 million for the first quarter of 2024, compared to $12.0 million for the same period in 2023.

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
星期一, 四月 1, 2024
FC, TME, Administration, Cell, Partnership, Patient, Gilead Sciences, Pharming, Research, Tumor microenvironment, G&A, Cancer, PacWest Bancorp, AACR, MSS, Investment, Therapy, CRC, Safety, Workforce, PD-1, Pharmaceutical industry

WALTHAM, Mass., April 01, 2024 (GLOBE NEWSWIRE) --  Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Xilio today reaffirmed plans to:
    Select a recommended Phase 2 dose for XTX101 in combination with atezolizumab in the second quarter of 2024.
  • In March 2024, Xilio and Gilead Sciences, Inc. (Gilead) announced an exclusive license agreement for Xilio’s tumor-activated IL-12 program, including XTX301.
  • Xilio will also be eligible to receive tiered royalties ranging from high single digits to mid-teens on annual global net product sales.
  • Net Loss: Net loss was $17.7 million for the quarter ended December 31, 2023, compared to $22.5 million for the quarter ended December 31, 2022.

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

Retrieved on: 
星期四, 三月 28, 2024
FC, Exchange, Partnership, Patient, Gilead Sciences, Pharming, Research, Sale, Cancer, PacWest Bancorp, Security (finance), Prospectus, Investment, RCC, Therapy, Safety, Melanoma, Workforce, IL-12, PacWest, Pharmaceutical industry

WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) --  Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that it has entered into a securities purchase agreement with certain existing accredited investors, including Bain Capital Life Sciences and Rock Springs Capital, to issue and sell an aggregate of 1,953,125 shares of Xilio common stock at a price of $0.64 per share and prefunded warrants to purchase up to an aggregate of 15,627,441 shares of Xilio common stock at a purchase price of $0.6399 per prefunded warrant share, through a private investment in public equity financing. The prefunded warrants will have an exercise price of $0.0001 per share of common stock, be immediately exercisable and remain exercisable until exercised in full. Xilio anticipates receiving aggregate gross proceeds from the private placement of approximately $11.3 million, before deducting placement agent fees and expenses payable by the company. The private placement is expected to close on April 2, 2024, subject to the satisfaction of customary closing conditions. Xilio expects to use the proceeds from the private placement to fund working capital and other general corporate purposes.

Key Points: 
  • Xilio anticipates receiving aggregate gross proceeds from the private placement of approximately $11.3 million, before deducting placement agent fees and expenses payable by the company.
  • The private placement is expected to close on April 2, 2024, subject to the satisfaction of customary closing conditions.
  • Xilio expects to use the proceeds from the private placement to fund working capital and other general corporate purposes.
  • Prior to the potential transition fee, Xilio is eligible to receive up to a total of $29.0 million in additional equity investments and a development milestone payment.

Banc of California Announces New Community Banking Leaders

Retrieved on: 
星期二, 四月 9, 2024
Finance, Business, Banking, Professional Services, Small Business, Baron, Banq, Commercial property, BANC, Banc of California, Warner Center, Los Angeles, PacWest Bancorp, Treasury, Disability, Bank

Banc of California, a wholly owned subsidiary of Banc of California Inc. (NYSE: BANC), announced today that it has promoted several leaders in Community Banking, which provides in-market relationship lending and treasury management solutions through its network of branches and regional offices.

Key Points: 
  • Banc of California, a wholly owned subsidiary of Banc of California Inc. (NYSE: BANC), announced today that it has promoted several leaders in Community Banking, which provides in-market relationship lending and treasury management solutions through its network of branches and regional offices.
  • Chris Baron has been promoted to President, Community Banking, to oversee Banc of California’s five regions in California and Colorado, along with its national asset-based lending business finance team.
  • Baron is based in Beverly Hills, California, and reports to Hamid Hussain, President of Banc of California.
  • In addition, he sits on the BANC Foundation board for Banc of California.

Credit and Loan Origination Industry Veteran Phil Soh Joins GreenLake Asset Management

Retrieved on: 
星期一, 三月 11, 2024
Citizens Business Bank, TAFE Queensland, BOC, Wachovia, Banc of California, PacWest Bancorp, Acquisition, LPL Financial, Banq, Financial services

LOS ANGELES, March 11, 2024 /PRNewswire/ -- GreenLake Asset Management ("GreenLake" or the "Firm"), a nationwide leader specializing in providing short-term commercial real estate bridge loans, today announced that Phil Soh has joined the Firm as a Managing Director. Mr. Soh will focus on new credit originations spanning the commercial real estate market. 

Key Points: 
  • LOS ANGELES, March 11, 2024 /PRNewswire/ -- GreenLake Asset Management ("GreenLake" or the "Firm"), a nationwide leader specializing in providing short-term commercial real estate bridge loans, today announced that Phil Soh has joined the Firm as a Managing Director.
  • Mr. Soh will focus on new credit originations spanning the commercial real estate market.
  • Mr. Soh brings to GreenLake more than two decades of experience in management, credit administration, underwriting and sales.
  • Before that, he held senior credit and business development positions at Citizens Business Bank and Wells Fargo / Wachovia Bank.

Banc of California Named by Newsweek as One of America’s Greatest Workplaces for Women 2024

Retrieved on: 
星期三, 三月 6, 2024
Technology, Women, Payments, Finance, Fintech, Banking, Professional Services, Small Business, DEI (Diversity, Equity and Inclusion), Consumer, Interface (computing), Banc of California, Workplace, Multimedia, Banq, Engagement, Culture, PacWest Bancorp, Inclusion, Workforce, BANC, Nursing

Banc of California, Inc. (NYSE: BANC) today announced that its wholly owned subsidiary and premier relationship-focused business bank, Banc of California, has been recognized by Newsweek and Plant-A Insights Group as one of America’s Greatest Workplaces for Women 2024 .

Key Points: 
  • Banc of California, Inc. (NYSE: BANC) today announced that its wholly owned subsidiary and premier relationship-focused business bank, Banc of California, has been recognized by Newsweek and Plant-A Insights Group as one of America’s Greatest Workplaces for Women 2024 .
  • Banc of California is one of only four companies in the banks category to earn five out of five stars.
  • View the full release here: https://www.businesswire.com/news/home/20240306989397/en/
    “Banc of California is thrilled to be recognized as having a great workplace for women,” said Jared Wolff, CEO of Banc of California.
  • To that end, Newsweek and Plant-A Insights are proud to introduce America’s Greatest Workplaces for Women.”

Bridge Bank’s Life Sciences Group Hires Phillip Ho in San Francisco

Retrieved on: 
星期四, 二月 22, 2024
Banking, Fintech, Professional Services, Finance, Senior, PacWest Bancorp, GE Capital, Multimedia, Pacific Northwest, BMO Capital Markets, Bank, Growth, JPMorgan Chase, Credit Suisse, Credit Suisse First Boston, Bridge bank, Management

Bridge Bank today announced that Phillip “Phil” Ho has joined its Life Sciences Group as senior vice president.

Key Points: 
  • Bridge Bank today announced that Phillip “Phil” Ho has joined its Life Sciences Group as senior vice president.
  • View the full release here: https://www.businesswire.com/news/home/20240222884279/en/
    Phillip “Phil” Ho, Senior Vice President in Bridge Bank’s Life Sciences Group.
  • (Photo: Business Wire)
    In his new role, Phil will support Bridge Bank’s Life Sciences Group in its mission to help companies in the industry bring their visions to market, working specifically with clients in the San Francisco Bay Area and the Pacific Northwest.
  • “I am excited to join Bridge Bank’s dynamic life sciences group and contribute to its forward-thinking approach to fostering innovation,” said Phil.

Banc of California and PacWest Bancorp Receive Stockholder Approvals for their Merger

Retrieved on: 
星期三, 十一月 22, 2023
Banq, Banc of California, PacWest, BANC, LOS, PacWest Bancorp

SANTA ANA, Calif. and LOS ANGELES, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Banc of California, Inc. (“Banc of California”) (NYSE: BANC) and PacWest Bancorp (“PacWest”) (Nasdaq: PACW) today jointly announced that, at their respective special meetings of stockholders held earlier today, they each received the necessary stockholder approval for the proposed combination of Banc of California and PacWest.

Key Points: 
  • SANTA ANA, Calif. and LOS ANGELES, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Banc of California, Inc. (“Banc of California”) (NYSE: BANC) and PacWest Bancorp (“PacWest”) (Nasdaq: PACW) today jointly announced that, at their respective special meetings of stockholders held earlier today, they each received the necessary stockholder approval for the proposed combination of Banc of California and PacWest.
  • The transaction is expected to close as planned on or around November 30, 2023, subject to the satisfaction of certain closing conditions.
  • “We are very pleased that the merger has received overwhelming approval from stockholders of each institution,” said Jared Wolff, President and CEO of Banc of California.
  • The merger also creates a well-capitalized and highly liquid institution that will provide our clients with exceptional service and expanded expertise.